PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: BEZ235|DRUG: BKM 120|DRUG: Letrozole|DRUG: BKM120
Sponsor: Vanderbilt-Ingram Cancer Center